Citations (12)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Marco Greco, Gaia Varriale, Giangennaro Coppola, Francesca Operto, Alberto Verrotti & Maria Laura Iezzi. (2018) Investigational small molecules in phase II clinical trials for the treatment of epilepsy. Expert Opinion on Investigational Drugs 27:12, pages 971-979.
Read now
Read now
David Pellerin, Audrey Lortie & François Corbin. (2018) Platelets as a surrogate disease model of neurodevelopmental disorders: Insights from Fragile X Syndrome. Platelets 29:2, pages 113-124.
Read now
Read now
Articles from other publishers (10)
Annunziata D’Elia, Sara Schiavi, Antonia Manduca, Alessandro Rava, Valeria Buzzelli, Fabrizio Ascone, Tiziana Orsini, Sabrina Putti, Andrea Soluri, Filippo Galli, Alessandro Soluri, Maurizio Mattei, Rosella Cicconi, Roberto Massari & Viviana Trezza. (2022) FMR1 deletion in rats induces hyperactivity with no changes in striatal dopamine transporter availability. Scientific Reports 12:1.
Crossref
Crossref
Reymundo Lozano, Talia Thompson, Jayne Dixon-Weber, Craig A. Erickson, Elizabeth Berry-Kravis, Sara Williams, Elizabeth Smith, Jean A. Frazier, Hilary Rosselot, Cristan Farmer & David Hessl. (2022) Observable Symptoms of Anxiety in Individuals with Fragile X Syndrome: Parent and Caregiver Perspectives. Genes 13:9, pages 1660.
Crossref
Crossref
Olivier Dionne & François Corbin. (2021) An “Omic” Overview of Fragile X Syndrome. Biology 10:5, pages 433.
Crossref
Crossref
Samantha T. Reyes, Sanaz Mohajeri, Karolina Krasinska, Scarlett G. Guo, Meng Gu, Laura Pisani, Jarrett Rosenberg, Daniel M. Spielman & Frederick T. Chin. (2020) GABA Measurement in a Neonatal Fragile X Syndrome Mouse Model Using 1H-Magnetic Resonance Spectroscopy and Mass Spectrometry. Frontiers in Molecular Neuroscience 13.
Crossref
Crossref
Ioannis Kramvis, Rhodé van Westen, Hanna C. A. Lammertse, Danai Riga, Tim S. Heistek, Alex Loebel, Sabine Spijker, Huibert D. Mansvelder & Rhiannon M. Meredith. (2020) Dysregulated Prefrontal Cortex Inhibition in Prepubescent and Adolescent Fragile X Mouse Model. Frontiers in Molecular Neuroscience 13.
Crossref
Crossref
Mireia Coll-Tané, Alina Krebbers, Anna Castells-Nobau, Christiane Zweier & Annette Schenck. (2019)
Intellectual disability and autism spectrum disorders ‘on the fly’: insights from
Drosophila
. Disease Models & Mechanisms 12:5.
Crossref
Crossref
Manman Niu, Ying Han, Angel Belle C. Dy, Junbao Du, Hongfang Jin, Jiong Qin, Jing Zhang, Qinrui Li & Randi J. Hagerman. (2017) Fragile X Syndrome: Prevalence, Treatment, and Prevention in China. Frontiers in Neurology 8.
Crossref
Crossref
D. Sinclair, R. Featherstone, M. Naschek, J. Nam, A. Du, S. Wright, K. Pance, O. Melnychenko, R. Weger, S. Akuzawa, M. Matsumoto & S. J. Siegel. (2017)
GABA-B Agonist Baclofen Normalizes Auditory-Evoked Neural Oscillations and Behavioral Deficits in the
Fmr1
Knockout Mouse Model of Fragile X Syndrome
. eneuro 4:1, pages ENEURO.0380-16.2017.
Crossref
Crossref
Zukhrofi Muzar, Reymundo Lozano, Alexander Kolevzon & Randi J. Hagerman. (2016) The neurobiology of the Prader-Willi phenotype of fragile X syndrome. Intractable & Rare Diseases Research 5:4, pages 255-261.
Crossref
Crossref
Hyeong-Min Lee & Yuna Kim. (2016) Drug Repurposing Is a New Opportunity for Developing Drugs against Neuropsychiatric Disorders. Schizophrenia Research and Treatment 2016, pages 1-12.
Crossref
Crossref